Initiation of Oligodendrocyte Progenitor Cell Migration by a PDGF-A Activated Extracellular Regulated Kinase (ERK) Signaling Pathway
Overview
Affiliations
During CNS development, oligodendrocyte progenitor (OP) cells migrate from germinal zones to presumptive white matter tracts to generate myelinating oligodendrocytes. In vitro and in vivo studies indicate that platelet-derived growth factor-A (PDGF-A) is a potent chemoattractant for OP cells and important for normal distribution throughout the developing CNS. However, PDGF-A does not localize in concentration gradients corresponding to OP migratory pathways, as would be expected for a chemoattractant to direct migration. Therefore, the mechanism by which PDGF-A regulates OP distribution remains to be clarified. Here we show that PDGF-A induces OP migration and continuous exposure to PDGF-A is not required to maintain migration. Using pharmacological inhibitors, we show that a self-sustaining extracellular-regulated-kinase signaling pathway drives OP migration for up to 72 hours after the initial PDGF stimulus. These findings indicate PDGF-A may act to mobilize OP cells that then respond to distinct directional signals to distribute appropriately within the CNS.
A New Acquaintance of Oligodendrocyte Precursor Cells in the Central Nervous System.
Ma Z, Zhang W, Wang C, Su Y, Yi C, Niu J Neurosci Bull. 2024; 40(10):1573-1589.
PMID: 39042298 PMC: 11422404. DOI: 10.1007/s12264-024-01261-8.
Making Ramón y Cajal proud: Development of cell identity and diversity in the cerebral cortex.
Di Bella D, Dominguez-Iturza N, Brown J, Arlotta P Neuron. 2024; 112(13):2091-2111.
PMID: 38754415 PMC: 11771131. DOI: 10.1016/j.neuron.2024.04.021.
p38γ MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions.
Marziali L, Hwang Y, Palmisano M, Cuenda A, Sim F, Gonzalez A Brain. 2023; 147(5):1871-1886.
PMID: 38128553 PMC: 11068213. DOI: 10.1093/brain/awad421.
Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling.
Bruschi M, Midjek L, Ajlil Y, Vairy S, Lancien M, Ghermaoui S Neuro Oncol. 2023; 26(3):553-568.
PMID: 37702430 PMC: 10912010. DOI: 10.1093/neuonc/noad161.
Dermitzakis I, Manthou M, Meditskou S, Miliaras D, Kesidou E, Boziki M Curr Issues Mol Biol. 2022; 44(7):3208-3237.
PMID: 35877446 PMC: 9324160. DOI: 10.3390/cimb44070222.